Skip to content

Clinical trials

Phase 3 Stroke trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: South Africa Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20062
20071
20081
20092
20101
20111
20121
20134
20143
20161
20181
20191
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Bayer3
AstraZeneca2
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Neurobiological Technologies2
Pfizer2
Sanofi2
CSL Behring1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke26
Myocardial Infarction11
Cardiovascular Diseases8
Atrial Fibrillation7
Coronary Artery Disease4
Heart Diseases4
Acute Coronary Syndrome3
Heart Failure3
Hyperlipidemias3
Ischemic Attack, Transient3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.